Elanco & Medgene Partnering on H5N1 Vaccine for Dairy Cattle

A new avian influenza vaccine for dairy cattle is moving one step closer to commercialization. Elanco Animal Health has an agreement with Brookings, South Dakota-based Medgene to bring this vaccine to market. USDA has already approved Medgene’s vaccine technology platform in cattle, allowing the accelerated development of the H5N1 vaccine. Medgene has existing vaccine supplies to deploy for this purpose. The product is in the final stages of review for conditional license approval.